Company Filing History:
Years Active: 2014
Title: Sayeh Ahrabi: Innovator in Parenteral Formulations
Introduction
Sayeh Ahrabi is a notable inventor based in Oslo, Norway. She has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of cancer. Her innovative work focuses on enhancing the delivery of therapeutic agents through parenteral methods.
Latest Patents
Sayeh Ahrabi holds a patent for "Parenteral formulations of elacytarabine derivatives." This invention relates to parenteral formulations for certain long-chain saturated and monounsaturated fatty acid derivatives of 1-β-D-arabinofuranosylcytosine (cytarabine). The patent aims to provide a parenteral pharmaceutical composition and a method of preparation that accommodates therapeutically effective doses of these derivatives, thereby improving compliance in cancer treatment. She has 1 patent to her name.
Career Highlights
Ahrabi is currently associated with Clavis Pharma ASA, where she continues to advance her research and development efforts. Her work is pivotal in creating effective treatment options for patients battling cancer.
Collaborations
Some of her notable coworkers include Finn Myhren and Ole Henrik Eriksen, who contribute to the collaborative environment at Clavis Pharma ASA.
Conclusion
Sayeh Ahrabi's innovative contributions to parenteral formulations represent a significant advancement in cancer treatment. Her dedication to improving therapeutic compliance through her patented work is commendable.